Počet záznamov: 1
Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherpy of unresectable liver metastases in colorectal cancer patients
SYS 0005537 LBL 00000naa--2200000-a-4500 005 20250607123420.8 008 080213c2008----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 080 $a 616.348/.35-006-06 $2 2001 080 $a 616.36-033.2-085 $2 2001 080 $a 615.277 $2 2001 242 10
$a Xelox (capecitabine a oxaliplatina) ako neoadjuvantná chemoterapia neresekovateľných metastáz v pečeni u pacientov s kolorektálnou rakovinou $y slo 245 10
$a Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherpy of unresectable liver metastases in colorectal cancer patients / $c U. Coskun ... [et al.] 300 $b ilustr., grafy, tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d015179 $a nádory kolorektálne $x komplikácie $2 mesh 650 12
$7 sllk_us_auth*d008113 $a nádory pečene $x sekundárne $2 mesh 650 12
$7 sllk_us_auth*d009362 $a metastázy nádorové $x farmakoterapia $x terapia $2 mesh 650 22
$7 sllk_us_auth*d020360 $a terapia neoadjuvantná $2 mesh 650 22
$7 sllk_us_auth*d000970 $a antineoplastiká $x použitie terapeutické $x toxicita $x účinky nežiaduce $2 mesh 650 22
$7 sllk_us_auth*d009944 $a zlúčeniny organoplatinové $x použitie terapeutické $2 mesh 650 22
$7 sllk_us_auth*d017741 $a preživší $x štatistika a číselné údaje $2 mesh 653 2-
$a metastázy pečeňové 653 2-
$a chemoterapia neoadjuvantná 653 2-
$a režim XELOX 700 1-
$7 sllk_us_auth*p0066022 $a Coskun, U. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001869 $a Buyukberber, S. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001870 $a Yaman, E. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*p0037000 $a Uner, A. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001876 $a Er, O. $u Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001877 $a Ozkan, M. $u Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001878 $a Dikilitas, M. $u Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001875 $a Oguz, M. $u Gazi University Medical School, Departments of Medical Surgery, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001871 $a Yildiz, R. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*p0031810 $a Yamac, D. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001872 $a Ozturk, B. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001873 $a Kaya, A. O. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 700 1-
$7 sllk_us_auth*0001885 $a Benekli, M. $u Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 aut 773 0-
$7 nnas $w sllk_us_cat*0005116 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2008 $g Vol. 55, no. 1 (2008), s. 65-70
Počet záznamov: 1